Viruses,
Год журнала:
2022,
Номер
14(2), С. 384 - 384
Опубликована: Фев. 14, 2022
The
evolution
of
the
SARS-CoV-2
virus
during
COVID-19
pandemic
was
accompanied
by
emergence
new
heavily
mutated
viral
variants
with
increased
infectivity
and/or
resistance
to
detection
human
immune
system.
To
respond
urgent
need
for
advanced
methods
and
materials
empower
a
better
understanding
mechanisms
virus’s
adaptation
host
cells
immuno-resistant
population,
we
suggested
using
recombinant
filamentous
bacteriophages,
displaying
on
their
surface
foreign
peptides
termed
“mimotopes”,
which
mimic
structure
receptor-binding
sites
spike
protein
can
serve
as
molecular
probes
in
evaluation
infectivity.
In
opposition
spike-binding
antibodies
that
are
commonly
used
studying
interaction
ACE2
receptor
vitro,
phage
mimotopes
targeted
other
cellular
receptors
would
allow
discovery
role
infection
vivo
cell
culture,
tissue,
organs,
or
whole
organism.
Phage
Spike
S1
have
been
developed
combination
display
mimicry
concepts,
here
“phage
mimicry”,
supported
bioinformatics
methods.
key
elements
concept
include:
(1)
preparation
collection
p8-type
(landscape)
phages,
interact
authentic
active
live
cells,
presumably
mimicking
binding
interactions
coronaviruses
such
its
variants;
(2)
closely
related
amino
acid
clusters
similar
3D
structural
motifs
natural
ligands
(FGF1
NRP1),
model
interest
FGFR
protein;
(3)
an
ELISA
analysis
between
candidate
FGFR3
(a
potential
alternative
receptor)
comparison
(the
receptor).
International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
23(3), С. 1716 - 1716
Опубликована: Фев. 2, 2022
The
review
aims
to
consolidate
research
findings
on
the
molecular
mechanisms
and
virulence
pathogenicity
characteristics
of
coronavirus
disease
(COVID-19)
causative
agent,
severe
acute
respiratory
syndrome
2
(SARS-CoV-2),
their
relevance
four
typical
stages
in
development
viral
infection.
These
are
invasion;
primary
blockade
antiviral
innate
immunity;
engagement
virus’s
protection
against
factors
adaptive
acute,
long-term
complications
COVID-19.
invasion
stage
entails
recognition
spike
protein
(S)
SARS-CoV-2
target
cell
receptors,
namely,
main
receptor
(angiotensin-converting
enzyme
2,
ACE2),
its
coreceptors,
potential
alternative
receptors.
presence
a
diverse
repertoire
receptors
allows
infect
various
types
cells,
including
those
not
expressing
ACE2.
During
second
stage,
majority
polyfunctional
structural,
non-structural,
extra
proteins
synthesizes
infected
cells
involved
blockage
immunity.
A
high
degree
redundancy
systemic
action
characterizing
these
pathogenic
overcome
at
initial
invasion.
third
includes
passive
active
virus
from
immunity,
overcoming
barrier
function
focus
inflammation,
generalization
body.
fourth
is
associated
with
deployment
variants
SARS-CoV-2’s
ability
induce
autoimmune
autoinflammatory
pathways
tissue
both
immunosuppressive
hyperergic
inflammation
critical
this
Cellular & Molecular Biology Letters,
Год журнала:
2022,
Номер
27(1)
Опубликована: Фев. 2, 2022
Abstract
The
novel
coronavirus
disease
2019
(COVID-19)
pandemic
has
spread
worldwide,
and
finding
a
safe
therapeutic
strategy
effective
vaccine
is
critical
to
overcoming
severe
acute
respiratory
syndrome
2
(SARS-CoV-2).
Therefore,
elucidation
of
pathogenesis
mechanisms,
especially
entry
routes
SARS-CoV-2
may
help
propose
antiviral
drugs
vaccines.
Several
receptors
have
been
demonstrated
for
the
interaction
spike
(S)
protein
with
host
cells,
including
angiotensin-converting
enzyme
(ACE2),
ephrin
ligands
Eph
receptors,
neuropilin
1
(NRP-1),
P2X7,
CD147.
expression
these
in
central
nervous
system
(CNS)
make
CNS
prone
invasion,
leading
neurodegenerative
diseases.
present
review
provides
potential
pathological
mechanisms
infection
CNS,
cytokines
involved
neuroinflammatory
conditions.
Moreover,
it
explains
several
disorders
associated
COVID-19.
Finally,
we
suggest
inflammasome
JaK
inhibitors
as
strategies
Nature Cardiovascular Research,
Год журнала:
2023,
Номер
2(10), С. 899 - 916
Опубликована: Сен. 28, 2023
Abstract
Patients
with
coronavirus
disease
2019
(COVID-19)
present
increased
risk
for
ischemic
cardiovascular
complications
up
to
1
year
after
infection.
Although
the
systemic
inflammatory
response
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
infection
likely
contributes
this
risk,
whether
SARS-CoV-2
directly
infects
coronary
vasculature
and
attendant
atherosclerotic
plaques
remains
unknown.
Here
we
report
that
viral
RNA
is
detectable
replicates
in
lesions
taken
at
autopsy
from
COVID-19
cases.
targeted
plaque
macrophages
exhibited
a
stronger
tropism
arterial
than
adjacent
perivascular
fat,
correlating
macrophage
infiltration
levels.
entry
was
cholesterol-loaded
primary
dependent,
part,
on
neuropilin-1.
induced
robust
cultured
human
vascular
explants
secretion
of
cytokines
known
trigger
events.
Our
data
establish
vessels,
inducing
inflammation
could
increase
long-term
risk.
TURKISH JOURNAL OF MEDICAL SCIENCES,
Год журнала:
2021,
Номер
51(SI-1), С. 3372 - 3390
Опубликована: Авг. 15, 2021
Currently
there
is
not
an
effective
antiviral
treatment
for
COVID-19,
but
a
large
number
of
drugs
have
been
evaluated
since
the
beginning
pandemic,
and
many
them
used
COVID-19
despite
preliminary
or
conflicting
results
clinical
trials.
We
aimed
to
review
summarize
all
current
knowledge
on
antivirals
COVID-19There
are
2
main
drug
groups
SARS-CoV-2:
agents
that
target
proteins
RNA
virus
interfere
with
biological
processes
in
host
support
virus.
The
include
inhibitors
viral
entry
into
human
cell
(convalescent
plasma,
monoclonal
antibodies,
nanobodies,
mini
proteins,
soluble
ACE-2,
camostat,
dutasteride,
proxalutamide,
bromhexin,
hydroxychloroquine,
umifenovir
nitazoxanid,
niclosamide,
lactoferrin),
proteases
(lopinavir/ritonavir,
PF-07321332,
PF-07304814,
GC376),
(remdesivir,
favipiravir,
molnupiravir,
AT-527,
merimepodib,
PTC299),
supporting
(plitidepsin,
fluvoxamine,
ivermectin),
natural
immunity
(Interferons).When
taking
account
available
laboratory
trials
subject,
antibodies
seem
be
most
at
moment,
high-titer
convalescent
plasma
also
could
when
administered
during
early
phase
disease.
As
lopinavir/ritonavir,
were
found
ineffective
RCTs,
they
should
used.
Additional
studies
needed
define
role
remdesivir,
interferons,
ivermectin,
proxulutamide,
bromhexine,
nitazoxanide,
niclosamid
COVID-19.
Finally,
waited
learn
whether
newer
such
as
plitidepsin
AT-527
ASN NEURO,
Год журнала:
2021,
Номер
13, С. 175909142110576 - 175909142110576
Опубликована: Янв. 1, 2021
Among
the
plethora
of
debilitating
neurological
disorders
COVID-19
syndrome
in
survivors,
scope
SARS-CoV-2-induced
dysautonomia
(DNS)
is
yet
to
be
understood,
though
implications
are
enormous.
Herein,
we
present
an
inclusive
mini-review
DNS
and
its
associated
complications.
Although,
direct
link
between
Covid-19
DSN
still
speculative,
hypothetical
links
thought
either
a
neuronal
injury
autonomic
pathway
or
para/post-infectious
immune-induced
mechanism.
SARS-CoV-2
infection-induced
stress
may
activate
sympathetic
nervous
system
(SNS)
leading
neuro-hormonal
stimulation
activation
pro-inflammatory
cytokines
with
further
development
storm.
Sympathetic
over-activation
correlated
increase
capillary
pulmonary
leakage,
alveolar
damage,
acute
respiratory
distress
syndrome.
Furthermore,
can
spread
through
mechanoreceptors
chemoreceptors
medullary
center
retrograde
manner
resulting
sudden
failure.
Taken
together,
developed
due
storm
inhibition
Parasympathetic
system-mediated
anti-inflammatory
effect
cytokine
Therefore,
storms
together
Renin-Angiotensin-System
chief
final
involved
Covid-19.
International Journal of Immunopathology and Pharmacology,
Год журнала:
2021,
Номер
35
Опубликована: Янв. 1, 2021
COVID-19
is
a
highly
heterogeneous
and
complex
medical
disorder;
indeed,
severe
probably
amongst
the
most
of
conditions
known
to
science.
While
enormous
strides
have
been
made
in
understanding
molecular
pathways
involved
patients
infected
with
coronaviruses
an
overarching
comprehensive
pathogenesis
lacking.
Such
essential
formulation
effective
prophylactic
treatment
strategies.
Based
on
clinical,
proteomic,
genomic
studies
as
well
autopsy
data
disease
can
be
considered
connection
three
basic
pathologic
processes,
namely
pulmonary
macrophage
activation
syndrome
uncontrolled
inflammation,
complement-mediated
endothelialitis
together
procoagulant
state
thrombotic
microangiopathy.
In
addition,
platelet
release
serotonin
degranulation
mast
cells
contributes
hyper-inflammatory
state.
Auto-antibodies
demonstrated
large
number
hospitalized
which
adds
end-organ
damage
pro-thrombotic
This
paper
provides
clinical
overview
major
pathogenetic
mechanism
leading
disease.
Journal of Clinical Medicine,
Год журнала:
2021,
Номер
10(13), С. 2772 - 2772
Опубликована: Июнь 24, 2021
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
discovered
in
2019,
is
responsible
for
the
global
disease
19
(COVID-19)
pandemic.
The
main
protein
that
interacts
with
host
cell
receptor
Spike-1
(S1)
subunit
of
coronavirus.
This
binds
receptors
present
on
membrane.
It
has
been
identified
from
several
studies
neuropilin-1
(NRP-1)
one
co-receptors
SARS-CoV-2
entry.
Therefore,
this
review,
we
focus
significance
NRP-1
infection.
MEDLINE/PubMed
database
was
used
a
search
available
literature.
In
current
report
plays
many
important
functions,
including
angiogenesis,
neuronal
development,
and
regulation
immune
responses.
Additionally,
presence
glycoprotein
membrane
significantly
augments
infection
spread
SARS-CoV-2.
Literature
data
suggest
facilitates
entry
virus
into
central
nervous
system
through
olfactory
epithelium
nasal
cavity.
Moreover,
published
findings
show
interfering
VEGF-A/NRP-1
using
inhibitors
may
produce
an
analgesic
effect.
review
describes
association
between
NRP-1,
and,
inter
alia,
pathological
changes
retina.
Based
findings,
very
mediator
implicated
in,
neurological
manifestations
it
appears
use
promising
therapeutic
strategy
treatment
International Journal of Molecular Sciences,
Год журнала:
2021,
Номер
22(15), С. 8255 - 8255
Опубликована: Июль 31, 2021
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2)
is
the
virus
responsible
for
COVID-19
pandemic.
Patients
may
present
as
asymptomatic
or
demonstrate
mild
to
severe
and
life-threatening
symptoms.
Although
has
a
respiratory
focus,
there
are
major
cardiovascular
complications
(CVCs)
associated
with
infection.
The
reported
CVCs
include
myocarditis,
heart
failure,
arrhythmias,
thromboembolism
blood
pressure
abnormalities.
These
occur,
in
part,
because
of
dysregulation
Renin–Angiotensin–Aldosterone
System
(RAAS)
Kinin–Kallikrein
(KKS).
A
route
by
which
SARS-CoV-2
gains
cellular
entry
via
docking
viral
spike
(S)
protein
membrane-bound
angiotensin
converting
enzyme
(ACE2).
roles
ACE2
within
immune
systems
vital
ensure
homeostasis.
key
routes
development
recently
described
long
COVID
have
been
hypothesised
direct
consequences
S
protein/ACE2
axis,
downregulation
resulting
damage
inflicted
response.
Here,
we
review
impact
on
system,
mechanisms
RAAS
KKS
can
occur
following
infection
future
implications
pharmacological
therapies.
Biomedicines,
Год журнала:
2022,
Номер
10(8), С. 2032 - 2032
Опубликована: Авг. 20, 2022
Severe
acute
respiratory
syndrome
coronavirus
type
2
(SARS-CoV-2)
infection
can
trigger
the
adaptive
and
innate
immune
responses,
leading
to
uncontrolled
inflammatory
reactions
associated
local
systematic
tissue
damage,
along
with
thromboembolic
disorders
that
may
increase
risk
of
ischemic
stroke
(AIS)
in
COVID-19
patients.
The
neuropilin
(NRP-1)
which
is
a
co-receptor
for
vascular
endothelial
growth
factor
(VEGF),
integrins,
plexins,
involved
pathogenesis
AIS.
NRP-1
also
regarded
as
entry
SARS-CoV-2
facilitates
its
into
brain
through
olfactory
epithelium.
cofactor
binding
angiotensin-converting
enzyme
(ACE2),
since
absence
ACE2
reduces
infectivity
even
presence
NRP-1.
Therefore,
aim
present
study
was
clarify
potential
role
patients
transmit
epithelium
nasal
cavity,
different
neurological
disorders,
therefore
about
45%
had
manifestations.
has
capability
attenuate
neuroinflammation,
blood-brain
barrier
(BBB)
permeability,
cerebral
dysfunction
(ED),
neuronal
are
uncommon
involvement,
including
Similarly,
high
serum
level
linked
ED,
oxidative
stress,
pulmonary
thrombosis
severe
COVID-19,
suggesting
compensatory
mechanism
overcome
immuno-inflammatory
disorders.
In
conclusion,
an
important
AIS,
could
be
biomarker
linking
development
AIS
COVID-19.
findings
cannot
provide
final
thus
silico,
experimental,
vitro,
vivo,
preclinical,
clinical
studies
recommended
confirm
elucidate
pharmacological
receptor
agonists
antagonists